For the Quarter Ending June 2026
Pregabalin Prices in North America
- In the United States, the Pregabalin Price Index rose in Q2 2026, driven by robust demand and increasing production costs.
- Production costs for Pregabalin increased in Q2 2026, with PPI rising 5.5% and CPI 3.5% year-over-year in June.
- Pregabalin demand was bolstered by strong retail sales, which grew 6.9% year-over-year in May 2026.
- A low 4.2% unemployment rate in June 2026 supported consumer spending and healthcare affordability for Pregabalin.
- Naphtha feedstock costs rebounded in Q2 2026, adding upward pressure on Pregabalin manufacturing expenses.
- Industrial production showed modest 0.7% expansion year-over-year in June 2026, affecting general input availability.
- Consumer confidence at 91.2 in June 2026 indicated stable spending, supporting Pregabalin demand.
- The Pregabalin price forecast suggests continued upward pressure due to sustained demand and elevated input costs in Q2 2026.
Why did the price of Pregabalin change in June 2026 in North America?
- Producer Price Index rose 5.5% year-over-year in June 2026, increasing Pregabalin production costs.
- Strong retail sales, up 6.9% year-over-year in May 2026, bolstered demand for healthcare products.
- Naphtha feedstock costs rebounded in Q2 2026, impacting manufacturing expenses for Pregabalin.
Pregabalin Prices in APAC
- In China, the Pregabalin Price Index rose quarter-over-quarter in Q2 2026, influenced by increasing production costs.
- Pregabalin production costs increased in June 2026, as the Producer Price Index rose 4.1% year-over-year.
- The Manufacturing Index expanded in June 2026, reflecting growth in the broader industrial sector.
- Industrial production grew 5.3% year-over-year in June 2026, supporting overall supply chain stability.
- Demand for Pregabalin was supported by steady pharmaceutical market growth in China during Q2 2026.
- Electricity prices for energy-intensive sectors increased in June 2026, elevating Pregabalin manufacturing expenses.
- Overseas buyers reduced orders for June 2026 due to elevated inventories of Chinese chemicals in May 2026.
- Crude oil imports significantly declined in May 2026, tightening energy feedstock supplies for chemical production.
- China's chemical exports strengthened between April and May 2026, contributing to a surging trade surplus in Q2 2026.
- The Consumer Price Index remained stable at 1.0% year-over-year in June 2026, indicating low inflation.
Why did the price of Pregabalin change in June 2026 in APAC?
- Production costs increased in June 2026, driven by a 4.1% rise in the Producer Price Index.
- Electricity prices for energy-intensive sectors rose in June 2026, impacting manufacturing expenses.
- Overseas demand softened in June 2026 as buyers reduced orders due to elevated inventories in May.
Pregabalin Prices in Europe
- In Germany, the Pregabalin Price Index rose quarter-over-quarter in Q2 2026, driven by rising production costs and stable demand.
- Pregabalin production costs increased in Q2 2026, influenced by a 2.2% rise in producer prices in May 2026.
- Demand for Pregabalin remained stable in Q2 2026, supported by a 1.8% increase in retail sales in May 2026.
- The Manufacturing Index showed a contracting trend in June 2026, impacting overall industrial activity.
- Elevated natural gas and naphtha feedstock costs persisted in Q2 2026, pressuring Pregabalin manufacturing expenses.
- Germany's consumer price index increased by 2.3% year-over-year in June 2026, affecting consumer purchasing power.
- A stable unemployment rate of 3.8% in May 2026 supported healthcare access and spending capacity.
- Shipping disruptions and elevated freight costs continued to limit imports and tighten supply in Q2 2026.
Why did the price of Pregabalin change in June 2026 in Europe?
- Producer prices for industrial products increased by 2.2% in May 2026, raising Pregabalin manufacturing costs.
- Elevated natural gas and naphtha feedstock costs in Q2 2026 contributed to higher production expenses.
- Shipping disruptions and increased freight costs in Q2 2026 tightened supply, exerting upward pressure.
For the Quarter Ending March 2026
Pregabalin Prices in North America
- In United States, the Pregabalin Price Index rose quarter-over-quarter in Q1 2026, reflecting elevated manufacturing costs.
- The Pregabalin Production Cost Trend increased in March 2026 as the Producer Price Index rose 4.0%.
- The Pregabalin Price Index faced upward pressure in March 2026 because consumer inflation reached 3.3%.
- The Pregabalin Demand Outlook strengthened in March 2026, supported by a 4.0% increase in retail sales.
- Stable patient access continued in March 2026, backed by 4.3% unemployment and 91.8 consumer confidence.
- The Manufacturing Index expanded in March 2026, while industrial production grew a modest 0.7% year-over-year.
- Pharmaceutical manufacturing expanded in Q1 2026, driving robust procurement for active pharmaceutical ingredients like pregabalin.
- Natural gas prices, a key energy input, decreased significantly in February 2026 due to milder temperatures.
- Generic pregabalin maintained a stable national supply inventory in Q1 2026, avoiding the active shortage list.
- The Pregabalin Price Forecast indicated upward momentum in March 2026 due to persistent inflation pressures.
Why did the price of Pregabalin change in March 2026 in North America?
- Elevated manufacturing input costs drove prices upward in March 2026, reflecting broader inflationary economic pressures.
- Robust pharmaceutical manufacturing activity in Q1 2026 increased procurement demand for essential active pharmaceutical ingredients.
- Modest industrial production growth of 0.7% in March 2026 constrained the domestic chemical supply availability.
Pregabalin Prices in APAC
- In China, the Pregabalin Price Index rose quarter-over-quarter in Q1 2026, driven by surging oil-linked costs.
- The Pregabalin Production Cost Trend increased in March 2026 as the PPI rose 0.5% year-over-year.
- The Pregabalin Demand Outlook remained steady in March 2026, supported by a 1.0% year-over-year CPI increase.
- Industrial production grew 5.7% year-over-year in March 2026, ensuring ample bulk API supply for the market.
- The Manufacturing Index expanded in March 2026, aligning with surged pharmaceutical API production during Q1 2026.
- Retail sales grew 1.7% and unemployment reached 5.4% in March 2026, pressuring premium branded medication sales.
- The Pregabalin Price Forecast stabilized in Q1 2026 as consumer confidence hit 86.0, limiting healthcare engagement.
- Technical grade diethyl malonate feedstock inventories swelled in Q1 2026, while Chinese export volumes remained robust.
Why did the price of Pregabalin change in March 2026 in APAC?
- Diethyl malonate feedstock costs spiked in Q1 2026 due to surging regional oil-linked energy expenses.
- The PPI rose 0.5% in March 2026, reflecting higher factory-gate prices for essential chemical precursors.
- Pharmaceutical API demand for diethyl malonate feedstock surged in Q1 2026, driving overall market consumption.
Pregabalin Prices in Europe
- In Germany, the Pregabalin Price Index rose quarter-over-quarter in Q1 2026, driven by severe feedstock shortages.
- The Pregabalin Production Cost Trend increased as March 2026 CPI reached 2.7%, reflecting higher energy expenses.
- Despite a -0.2% PPI decline in March 2026, Pregabalin API manufacturer margins faced upstream supply constraints.
- The Manufacturing Index expanded in March 2026, reflecting robust pharmaceutical processing activity for Pregabalin formulations.
- Industrial production remained stagnant at 0.0% in February 2026, while retail sales grew 0.7%, supporting demand.
- A stable 4.2% unemployment rate in February 2026 ensured patient access, boosting the Pregabalin Demand Outlook.
- A major German producer declared force majeure on isovaleraldehyde in Q1 2026, severely restricting local supply.
- Acrylonitrile feedstock costs surged in Q1 2026 as Middle Eastern disruptions extended European transit times.
- The Pregabalin Price Forecast indicated upward pressure in March 2026 due to tightened global inventory levels.
Why did the price of Pregabalin change in March 2026 in Europe?
- Acrylonitrile feedstock costs surged sharply in Q1 2026 due to severe global geopolitical shipping disruptions.
- A major German producer declared force majeure on the critical precursor isovaleraldehyde during Q1 2026.
- Downstream pharmaceutical manufacturing demand strengthened significantly in February 2026, driving up overall regional market consumption.
For the Quarter Ending December 2025
Pregabalin Prices in North America
- In the United States, the Pregabalin Price Index rose quarter-over-quarter in Q4 2025, driven by robust pharmaceutical demand.
- Pregabalin production costs increased in December 2025, as the Producer Price Index rose 3.3% year-over-year.
- Demand for Pregabalin was supported by the US pharmaceutical market's outperformance during Q4 2025.
- The Pregabalin demand outlook remained positive, bolstered by 3.9% retail sales growth year-over-year in December 2025.
- Industrial production expanded 2.0% year-over-year in December 2025, indicating stronger manufacturing activity.
- The US chemical industry experienced significant overcapacity throughout 2025, impacting overall supply dynamics.
- Consumer confidence, at 89.1 in December 2025, supported spending despite a 2.7% CPI rise.
- A low unemployment rate of 4.4% in December 2025 indicated a strong labor market and consumer purchasing power.
Why did the price of Pregabalin change in December 2025 in North America?
- Rising input costs, evidenced by a 3.3% year-over-year increase in the Producer Price Index in December 2025.
- Strong demand from the healthcare/pharmaceuticals sector, which outperformed in Q4 2025.
- Robust consumer spending, with retail sales increasing 3.9% year-over-year in December 2025.
Pregabalin Prices in APAC
- In China, Pregabalin Price Index remained stable in Q4 2025, influenced by weak demand and mixed production costs.
- Pregabalin production costs faced upward pressure from elevated urea feedstock costs in November 2025.
- However, the Producer Price Index declined by 1.9% year-over-year in December 2025, easing overall producer-level prices.
- Pregabalin demand was subdued in Q4 2025, with retail sales growth at 0.9% year-over-year in December 2025.
- Consumer confidence cooled in Q4 2025, impacting prescription drug demand due to cautious spending.
- China's industrial production grew 5.2% year-over-year in December 2025, supporting stable pharmaceutical supply chains.
- The Manufacturing Index expanded in December 2025, indicating growth in the broader industrial environment.
- Medicine exports from China, including APIs, steadily increased in the first 11 months of 2025.
- The prices for Pregabalin in Q4, 2025 settled at USD 60,000/MT in Asia.
Why did the price of Pregabalin change in December 2025 in APAC?
- Weak consumer spending, with 0.9% retail sales growth in December 2025, dampened Pregabalin demand.
- Producer Price Index declined 1.9% year-over-year in December 2025, easing overall production costs.
- Elevated urea feedstock costs in November 2025 and rising sulfur costs in Q4 2025 pressured costs.
Pregabalin Prices in Europe
- In Germany, the Pregabalin Price Index fell quarter-over-quarter in Q4 2025, influenced by decreasing producer costs and competitive pressures.
- Pregabalin production costs declined as the Producer Price Index decreased by 2.5% year-over-year in December 2025.
- Despite a 1.8% rise in the Consumer Price Index in December 2025, overall producer input costs for Pregabalin decreased.
- High energy and raw material costs, particularly natural gas, persistently burdened the German chemical industry throughout 2025.
- Demand for Pregabalin was supported by moderate pharmaceutical market growth in 2025, driven by an aging population.
- Retail sales increased by 1.8% year-over-year in December 2025, indirectly supporting healthcare spending and patient access.
- The unemployment rate remained low at 3.8% in December 2025, contributing to stable patient affordability for medications.
- Industrial production remained stable at 0.0% year-over-year in October 2025, reflecting a stagnant broader economic environment.
Why did the price of Pregabalin change in December 2025 in Europe?
- The Producer Price Index decreased by 2.5% year-over-year in December 2025, reducing manufacturing input costs.
- Increased competitive pressures from abroad prompted German chemical companies to lower price plans in October 2025.
- Weak external demand and low consumer confidence (-12.0 in December 2025) dampened overall market sentiment.
For the Quarter Ending September 2025
APAC
- In China, the Pregabalin Price Index fell quarter-over-quarter in Q3 2025, driven by weak consumer demand.
- Pregabalin production costs were stable in Q3 2025, influenced by steady petrochemical feedstock costs.
- The demand outlook for Pregabalin faced moderation due to overall economic growth slowing in China during Q3 2025.
- China's Consumer Price Index declined 0.3% year-over-year in September 2025, signaling deflation and reduced purchasing power.
- Producer Price Index decreased 2.3% year-over-year in September 2025, reflecting lower input costs and weak industrial demand.
- The Manufacturing Index contracted in September 2025, indicating reduced industrial activity impacting the supply chain.
- Industrial production grew 6.5% year-over-year in September 2025, supporting a stable supply of chemical precursors.
- Global overcapacity in the chemicals sector, significantly influenced by China's expanding production, persisted in Q3 2025.
Why did the price of Pregabalin change in September 2025 in APAC?
- Weak consumer demand, with CPI declining 0.3% in September 2025, pressured Pregabalin prices.
- Producer Price Index fell 2.3% in September 2025, reflecting lower input costs and weak industrial demand.
- Contracting Manufacturing Index and 5.2% unemployment in September 2025 dampened overall market confidence.
Europe
- In Germany, the Pregabalin Price Index remained stable quarter-over-quarter in Q3 2025, balancing declining petrochemical costs with strong demand.
- Pregabalin production costs were influenced by a 1.7% decline in producer prices in September 2025, driven by lower energy costs.
- Elevated natural gas and electricity prices in Q3 2025 continued to challenge overall chemical manufacturing costs.
- Demand for Pregabalin saw a boost in Q3 2025, as German pharmaceutical sector output firmed.
- The Manufacturing Index contracted in Q3 2025, indicating broader industrial weakness, potentially impacting supply chains.
- Industrial production declined by 1.0% in September 2025, reflecting a weaker manufacturing environment for intermediates.
- Retail sales increased by 0.2% in September 2025, supporting stable consumer spending and healthcare system funding.
- The unemployment rate remained stable at 6.3% in September 2025, contributing to consistent consumer purchasing power.
- Pregabalin price forecast suggests continued stability, with strong pharmaceutical demand offsetting persistent high energy costs.
Why did the price of Pregabalin change in September 2025 in Europe?
- Producer prices fell 1.7% in September 2025, due to lower energy costs, reducing Pregabalin manufacturing expenses.
- Strong pharmaceutical demand in Q3 2025, with firming sector output, provided upward pressure on Pregabalin prices.
- Elevated natural gas and electricity prices in Q3 2025 continued to exert upward pressure on Pregabalin production costs.
North America
- In United States, the Pregabalin Price Index rose quarter-over-quarter in Q3 2025, driven by increasing production costs and robust pharmaceutical demand.
- Pregabalin production costs increased due to a 2.6% rise in PPI in August 2025 and strengthened natural gas prices in September 2025.
- Pregabalin demand outlook was supported by robust US pharmaceutical demand in 2025 and a 5.42% rise in retail sales in September 2025.
- Wholesale chemical inventories eased in July 2025, suggesting a balanced supply-demand environment.
- US chemical imports rose in July 2025, narrowing the chemical trade surplus for the quarter.
- Overall industrial production saw a marginal 0.1% year-over-year increase in September 2025, indicating slower economic expansion.
- Declining consumer confidence and a 4.3% unemployment rate in September 2025 impacted healthcare spending.
- The 3.0% year-over-year CPI increase in September 2025 contributed to higher operational costs for manufacturers.
- US manufacturing output rose in August 2025, following a July decrease, indicating some industrial activity recovery.
Why did the price of Pregabalin change in September 2025 in North America?
- Production costs increased due to a 2.6% rise in PPI in August 2025 and strengthened natural gas prices.
- Robust US pharmaceutical demand in 2025 supported prices, despite declining consumer confidence in September 2025.
- Wholesale chemical inventories eased in July 2025, influencing supply dynamics and price stability.
